MESSAGE FROM THE EDITOR-IN-CHIEF  by Raoult, D.
D. Raoult
Editor-in-Chief
This issue of CMI really corresponds to the evolution that
we wished to have for the journal. CMI is the journal of a
society, the European Society of Clinical Microbiology and
Infectious Diseases, and as such it should help to promote
quality science and, more particularly, the science emanating
from the society.
In conjunction with the aim of promoting science of qual-
ity, the journal aims to train new editors for the future of
the journal. Thus, 15 associate editors have assumed autono-
mous responsibility for the peer review and revision process
of all submitted articles, and the responsible editor is named
on the title page of the published article.
CMI has several new aspects as of January 2009:
Each monthly issue will have a theme section with reviews
that have been commissioned by an Associate Editor or by
an invited expert.
In order to allow us to publish more high quality material,
the size of research articles has been substantially reduced,
with a standardized length of 1000 words for research notes
and 2500 words for full articles.
Neither clinical reports nor items of correspondence that
describe case studies are invited for submission, and reviews
will generally be limited to those invited for theme sections.
The journal wishes to welcome articles with a break-
through potential in a column called ‘research letters’. Such
submissions should deal with important, spectacular prelimin-
ary data, and will beneﬁt from a fast-track system for rapid
on-line publication.
Coloured documents will be available and downloadable
on the journal site.
As in the past, we believe that it is essential to have a
short deadline between submission and publication, and will
maintain the consistently high rate of initial rejection, based
on the reality that we publish approximately 20% of the sub-
mitted articles. The decisions to decline submissions prior to
external review are made by myself, in conjunction with the
team of Associate Editors.
The journal is open to appeals from authors who feel
their submission has been unfairly judged, and such requests
for reconsideration should be addressed to the Editor-in-
Chief.
Concerning Supplements to the journal, the Supplements
Editor and I agree that the articles should be comparable to
those published in monthly issues and thus beneﬁt from peer
review. Educational Supplements will be ﬁnanced or co-
ﬁnanced by the Society in order to ensure a broad range of
subjects.
Finally, in order to avoid any conﬂict of interest, I will not
submit articles during my term of ofﬁce. The articles on
which I have been a co-author which have been published in
2008 were scheduled before I started my term as the edi-
tor-in-chief several months earlier than anticipated, in April
2008.
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